Covington & Burling advised AbbVie on the transaction, and Fenwick & West advised Aliada Therapeutics. AbbVie (NYSE: ABBV), a pharmaceutical firm, announced it has entered into...
You must be a Standard 1 Year member to access this content.
White & Case LLP has successfully led AbbVie Inc. and several other pharmaceutical companies, as co-defendants, to secure a dismissal with prejudice in the case. In...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz served as legal advisor to AbbVie on the transaction. AbbVie Inc. issued and sold $15.0 billion aggregate principal amount of senior...
You must be a Standard 1 Year member to access this content.
Ropes & Gray advised AbbVie on the deal. AbbVie (NYSE: ABBV), and Umoja Biopharma (Umoja) Umoja Biopharma announced two exclusive option and license agreements to develop multiple in-situ...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised AbbVie, Latham & Watkins advised Cerevel Therapeutics, Skadden advised Centerview partners LLC, as financial advisor to Cerevel Therapeutics in the transaction. AbbVie...
You must be a Standard 1 Year member to access this content.
Wachtell, Lipton, Rosen & Katz served as legal advisor to AbbVie, while Ropes & Gray served as legal advisor to ImmunoGen. AbbVie Inc. (NYSE: ABBV) and...
You must be a Standard 1 Year member to access this content.
Robbins Geller Rudman & Dowd, Seeger Weiss Newark, Plevin & Gallucci, Bertram & Graf, Irpino, Avin & Hawkins, Powell & Majestro, Dugan Law Firm, Cooper Law...
You must be a Standard 1 Year member to access this content.
Jones Day advised AbbVie Inc on the deal. Mitokinin, Inc., a biotechnology company developing PINK1-targeted therapeutics for the treatment of neurodegenerative diseases, announced that AbbVie, a leading...
You must be a Standard 1 Year member to access this content.
